Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Kwok Seng, Loh"'
Autor:
Raymond Chee Seong Seet, Amy May Lin Quek, Delicia Shu Qin Ooi, Sharmila Sengupta, Satish Ramapatna Lakshminarasappa, Chieh Yang Koo, Jimmy Bok Yan So, Boon Cher Goh, Kwok Seng Loh, Dale Fisher, Hock Luen Teoh, Jie Sun, Alex R. Cook, Paul Anantharajah Tambyah, Mikael Hartman
Publikováno v:
International Journal of Infectious Diseases, Vol 106, Iss , Pp 314-322 (2021)
Background: We examined whether existing licensed pharmacotherapies could reduce the spread of coronavirus disease 2019 (COVID-19). Methods: An open-label parallel randomized controlled trial was performed among healthy migrant workers quarantined in
Externí odkaz:
https://doaj.org/article/72afc2d8d21940c4bc951d20c1822ae3
Autor:
Xinni Xu, Anil Gopinathan, Yew Kwang Ong, Mark Kim Thye Thong, Woei Shyang Loh, Kwok Seng Loh
Publikováno v:
Head & Neck. 45:1604-1614
Autor:
Fenggang Yu, Nicholas L. Syn, Yanan Lu, Qing Yun Chong, Junyun Lai, Wei Jian Tan, Boon Cher Goh, Paul A. MacAry, Lingzhi Wang, Kwok Seng Loh
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Epstein-Barr virus (EBV)—the prototypical human tumor virus—is responsible for 1–2% of the global cancer burden, but divergent strains seem to exist in different geographical regions with distinct predilections for causing lymphoid or epithelia
Externí odkaz:
https://doaj.org/article/c7d3b1b7e94444d6a7d06062f782d2a5
Autor:
Sudipta Samanta, Muthukaruppan Swaminathan, Jianing Hu, Khai Tuck Lee, Ajitha Sundaresan, Chuan Keng Goh, Chor Hiang Siow, Kwok Seng Loh, Soh Ha Chan, Joshua K. Tay, Ian Cheong
Publikováno v:
The American Journal of Pathology. 192:1295-1304
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 279:5851-5858
To review the effectiveness and safety of embolisation in managing haemorrhage from the external carotid artery (ECA) system in radiated nasopharyngeal carcinoma (NPC) patients.Radiated NPC patients who presented with severe oronasal bleeding and und
Autor:
Louise Soo Yee Tan, Benjamin Wong, Nagaraja Rao Gangodu, Andrea Zhe Ern Lee, Anthony Kian Fong Liou, Kwok Seng Loh, Hao Li, Ming Yann Lim, Andres M. Salazar, Chwee Ming Lim
Publikováno v:
OncoImmunology, Vol 7, Iss 11 (2018)
Cetuximab immunotherapy targeting the epidermal growth factor receptor (EGFR) has been used to treat nasopharyngeal cancer (NPC) with some success. Therefore, combining an immune adjuvant to boost the immune microenvironment may improve its clinical
Externí odkaz:
https://doaj.org/article/27f9db9d56734352801c1895d20e80dd
Autor:
H. Phillip Koeffler, De-Chen Lin, Jeffrey W. Tyner, Samantha Savage, Marilynn Chow, Thomas Kwok Seng Loh, Yanan Lu, Fenggang Yu, Han Lin, Ling-Wen Ding, Moli Huang, Anand Mayakonda, Yan-Yi Jiang, Jiang Yuan
Nasopharyngeal carcinoma (NPC) is an invasive cancer with particularly high incidence in Southeast Asia and Southern China. The pathogenic mechanisms of NPC, particularly those involving epigenetic dysregulation, remain largely elusive, hampering cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00867f47211556541ab18f00ce467b5d
https://doi.org/10.1158/0008-5472.c.6509139.v1
https://doi.org/10.1158/0008-5472.c.6509139.v1
Autor:
H. Phillip Koeffler, De-Chen Lin, Jeffrey W. Tyner, Samantha Savage, Marilynn Chow, Thomas Kwok Seng Loh, Yanan Lu, Fenggang Yu, Han Lin, Ling-Wen Ding, Moli Huang, Anand Mayakonda, Yan-Yi Jiang, Jiang Yuan
The IC50 (nM) values, RNA-seq, ChIP seq and motif analysis in NPC cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eaab05df362afef09b18d20fd02c768
https://doi.org/10.1158/0008-5472.22414995
https://doi.org/10.1158/0008-5472.22414995
Autor:
Boon Cher Goh, Yaw Chyn Lim, Bee Choo Tai, Kwok Seng Loh, Soo Chin Lee, Siew Meng Chong, Francis Cho Hao Ho, Robby Miguel Goh, Yu Yang Soon, Jieying Amelia Lau, Ross Andrew Soo, Li Ren Kong, Andrea L. Wong, Lingzhi Wang, Kritika Yadav, Joshua K. Tay, Woei Shyang Loh, Anand D. Jeyasekharan, Raghav Sundar, Nesaretnam Barr Kumarakulasinghe, Yiqing Huang, Gloria Hui Jia Chan, Chee Seng Tan, Arvind Kumar Sinha, Chwee Ming Lim, Wan Qin Chong
Figure S1- Study schema Figure S2 - Example of complete metabolic response after 3 cycles of induction therapy in a representative Arm C patient treated with bevacizumab at 7.5mg/kg in combination with cisplatin and gemcitabine. Figure S3- Relapse fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e5ca384132530be682642d44168375f
https://doi.org/10.1158/1078-0432.22476369
https://doi.org/10.1158/1078-0432.22476369
Autor:
Boon Cher Goh, Yaw Chyn Lim, Bee Choo Tai, Kwok Seng Loh, Soo Chin Lee, Siew Meng Chong, Francis Cho Hao Ho, Robby Miguel Goh, Yu Yang Soon, Jieying Amelia Lau, Ross Andrew Soo, Li Ren Kong, Andrea L. Wong, Lingzhi Wang, Kritika Yadav, Joshua K. Tay, Woei Shyang Loh, Anand D. Jeyasekharan, Raghav Sundar, Nesaretnam Barr Kumarakulasinghe, Yiqing Huang, Gloria Hui Jia Chan, Chee Seng Tan, Arvind Kumar Sinha, Chwee Ming Lim, Wan Qin Chong
Supplementary methods and supplementary tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ed931be1b96f314d7ba7ec572b65b3
https://doi.org/10.1158/1078-0432.22476375
https://doi.org/10.1158/1078-0432.22476375